CVS Group (CVSG)

Sector:

Retailers

Index:

FTSE AIM 50

 818.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,704.00p
  • 52 Week Low: 798.00p
  • Currency: UK Pounds
  • Shares Issued: 71.74m
  • Volume: 0
  • Market Cap: £586.83m
  • RiskGrade: 136
  • Beta: 0.01

CVS Group dogged by shortage of vets

By Duncan Ferris

Date: Thursday 29 Nov 2018

LONDON (ShareCast) - (Sharecast News) - CVS Group's shares dropped ahead of its annual general meeting on Thursday as a warning about a squeeze on margins due to the continued shortage of veterinary surgeons and nurses overrode news of continued sales growth.
For the four-month period ended 31 October the veterinary services provider's total sales increased by 24.7% compared to the same period last year, or up 4.7% when new acquisitions were excluded.

Elsewhere, Animed sales jumped by 14.9%, Crematoria's increased by 12.4% and Laboratory sales rose by 7.8% as CVS kept up the pace of acquisitions.

In the year to date the AIM-listed company has acquired 19 practices and instrument and equipment supply business Vet Direct for a total of £48.4m, and reports that the performance of new acquisitions has been "fully in line" with its business plan.

"The group continues to have a strong pipeline of acquisition opportunities and we expect to complete a number of further acquisitions in the remainder of the current financial year and beyond. CVS will continue to be selective and will seek acquisitions where they complement the existing business and where acquisition multiples are acceptable," CVS said in a statement.

Directors also noted the continued industry headwinds in relation to the shortage of veterinary surgeons and nurses, with a continued need to rely on locums for flexibility, while market rates for veterinary locums have increased around 14% over the same period last year.

This and other cost inflation factors has resulted in profit margins for the group declining year-on-year.

In recruitment, the company welcomed a record 130 new graduate vets into its two-year graduate induction programme and also reported reductions in vacancies for surgeons and nurses after raising wages above industry standards to deal with a shortage of qualified individuals.

The period also saw the launch of a return-to-work programme to support veterinary surgeons and nurses who wish to return to the profession and a "women in leadership" programme to ensure equal opportunities for career progression.

CVS' shares were down 8.74% at 663.00p at 0854 GMT.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CVS Group Market Data

Currency UK Pounds
Share Price 818.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,704.00p
52 Week Low 798.00p
Volume 0
Shares Issued 71.74m
Market Cap £586.83m
Beta 0.01
RiskGrade 136

CVS Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
0.07% below the market average0.07% below the market average0.07% below the market average0.07% below the market average0.07% below the market average
17.95% below the sector average17.95% below the sector average17.95% below the sector average17.95% below the sector average17.95% below the sector average
Price Trend
70.09% below the market average70.09% below the market average70.09% below the market average70.09% below the market average70.09% below the market average
69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average
Income
87.25% below the market average87.25% below the market average87.25% below the market average87.25% below the market average87.25% below the market average
90% below the sector average90% below the sector average90% below the sector average90% below the sector average90% below the sector average
Growth
46.9% below the market average46.9% below the market average46.9% below the market average46.9% below the market average46.9% below the market average
23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average

What The Brokers Say

Strong Buy 4
Buy 4
Neutral 1
Sell 1
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CVS Group Dividends

  Latest Previous
  Final Final
Ex-Div 31-Oct-24 02-Nov-23
Paid 29-Nov-24 08-Dec-23
Amount 8.00p 7.50p

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

CVS Group Key Personnel

CEO Richard Fairman
Finance Director Robin Alfonso

Top of Page